Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 125 of 144 pages ‹ First < 123 124 125 126 127 > Last ›
HSL18144
Neville E.
British Thoracic Society corrects damaging impression.
BMJ 2003 May 31; 326:(7400):1211-2
http://bmj.com/cgi/content/full/326/7400/1211-c
HSL18145
Napier JC, Francis R, Wright G.
Shared scheme for assessing drugs for multiple sclerosis: cost effective provision of effective treatments for multiple sclerosis.
BMJ 2003 May 31; 326:(7400):1212
http://www.bmj.com/cgi/content/full/326/7400/1212?view=long&pmid=12775633
HSL18146
Chadwick D, Gray R.
Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem.
BMJ 2003 May 31; 326:(7400):1212-3
http://www.bmj.com/cgi/content/full/326/7400/1212-a?view=long&pmid=12775632
HSL1166
Doctors 'influenced by drug companies'
BBC News 2003 May 30
http://news.bbc.co.uk/2/hi/health/2946276.stm
HSL5478
Mansfield PR.
Free offer for all BMJ readers from Healthy Skepticism
BMJ 2003 May 30; 326:
http://bmj.bmjjournals.com/cgi/eletters/326/7400/1205
HSL7453
Petersen M.
Court Papers Suggest Scale Of Drug's Use
New York Times 2003 May 30
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9502E6DD1630F933A05756C0A9659C8B63
HSL10473
Steinbrook R.
HIV infection--a new drug and new costs.
N Engl J Med 2003 May 29; 348:(22):2171-2
http://content.nejm.org/cgi/content/extract/348/22/2171
HSL17938
Simmons Hotz A
Poison for Profit - What A Business Plan!
Mercola.com 2003 May 29
HSL18147
Moynihan R
The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers
BMJ 2003 May 29; 326:(7400):1218
http://www.bmj.com/cgi/content/full/326/7400/1218
HSL18148
Jackson T
Regulator spells out rules on disease awareness campaigns
BMJ 2003 May 29; 326:(7400):1219
http://www.bmj.com/cgi/content/full/326/7400/1219-a
HSL18149
Bonaccorso S, Smith R
In praise of the 'devil'
BMJ 2003 May 29; 326:(7400):1220
http://www.bmj.com/cgi/content/full/326/7400/1220
HSL18150
Müllner M
Doctors and the drug industry
BMJ 2003 May 29; 326:(7400):1220
http://www.bmj.com/cgi/content/full/326/7400/1220-a
HSL18151
Belcher P
How not to do medical research
BMJ 2003 May 29; 326:(7400):1221
http://www.bmj.com/cgi/content/full/326/7400/1221
HSL1160
Moynihan R.
The shocking truth on HRT
The Age (Melbourne, Australia) 2003 May 28
http://www.theage.com.au/articles/2003/05/27/1053801392049.html
HSL1162
Grady D.
Hormone Use Found to Raise Dementia Risk
The New York Times 2003 May 28
http://www.nytimes.com/2003/05/28/us/hormone-use-found-to-raise-dementia-risk.html?pagewanted=1
HSL1165
Vergano D.
Little children suffer in search for cures
USA TODAY 2003 May 28
HSL1158
Schiff I.
More bad news for hormone therapy: Study finds treatment may increase risk of dementia
Associated Press 2003 May 27
HSL1159
Hormone Therapy Doubles Risk Of Dementia: Network Calls For Curbs On Drug Company Influence Over Prescribing
National Women's Health Network 2003 May 27
HSL1154
Buck T.
EU acts to speed up flow of cheap Aids drugs
2003 May 26
HSL1156
Quinn E.
Drugs giant to face Irish Seroxat lawsuits
The Sunday Business Post 2003 May 26
HSL1151
Kowalczyk L.
Drug companies' secret reports outrage doctors
Boston Globe 2003 May 25
HSL1152
Revill J.
Probe into 'happy pill' after a spate of suicides: Government bows to pressure over Prozac and Seroxat
The Observer 2003 May 25
http://www.guardian.co.uk/politics/2003/may/25/uk.mentalhealth
HSL1149
FDA Reports More Than Half of Post-Approval Prescription Drug Studies Not Begun
California Healthline 2003 May 23
HSL1140
Bogdanich W.
2 Paths of Bayer Drug in 80's: Riskier Type Went Overseas
New York Times 2003 May 22
http://www.nytimes.com/2003/05/22/business/2-paths-of-bayer-drug-in-80-s-riskier-one-steered-overseas.html
HSL1141
Koppel N.
Patents Making Drugs Too Expensive
The Associated Press 2003 May 22
HSL1142
Evans R.
Campaigners urge world pact to make drugs for poor
Reuters 2003 May 22
HSL1144
Pugh T.
Many want to pull plug on The Patient Channel
Knight Ridder Newspapers 2003 May 22
HSL1145
Silverman E.
The Canada Connection: Drugs cheaper, if more controversial, through our northern friends
The Star-Ledger 2003 May 22
HSL1146
Bayer sold risky drug abroad: Drugmaker’s medication spread HIV to consumers overseas
Associated Press 2003 May 22
HSL1136
Boseley S.
Guardian on WHO/HAI drug pricing report: Pricing policies exposed
The Guardian 2003 May 21
HSL1137
Carroll R.
Africa's Aids drugs trapped in the laboratory: Kenya has the pills. Now the fight is on to get them to the people
The Guardian 2003 May 21
http://www.guardian.co.uk/world/2003/may/21/aids.rorycarroll
HSL1139
Unprecedented public response to evidence of SSRI drug harm
BBC Panorama 2003 May 21
HSL10487
Jaffe JH, O'Keeffe C.
From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.
Drug Alcohol Depend 2003 May 21; 70:(2):
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T63-4871JJ1-3&_user=10&_coverDate=05%2F21%2F2003&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=13712ceb372225aca8cbc77cce983519
HSL1134
Goode E.
Leading Drugs for Psychosis Come Under New Scrutiny
The New York Times 2003 May 20
http://query.nytimes.com/gst/health/article-printpage.html?res=990CE0DB103EF933A15756C0A9659C8B63
HSL1135
Moyers S.
Emerson backs bill to allow 'reimport' of U.S. drugs
Southeast Missourian 2003 May 20
HSL1132
Cook M.
Time to put drug giants on trial
The Scotsman 2003 May 19
HSL1131
Berenson A.
Trial Lawyers Are Now Focusing on Lawsuits Against Drug Makers
2003 May 18
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9406E2DD123EF93BA25756C0A9659C8B63
HSL17956
Kowalczyk L
Ruling sought against Pfizer: Federal prosecutors say anticonvulsant marketed illegally
The Boston Globe 2003 May 18
HSL10463
Treves-Brown KM, Antony FJO, Baker KB, Miller DJS, Young RC, Baird JH
Supply of veterinary medicines.
Vet Rec 2003 May 17; 152:(20):635
HSL10483
Laing R, Waning B, Gray A, Ford N, 't Hoen E.
25 years of the WHO essential medicines lists: progress and challenges.
Lancet 2003 May 17; 361:(9370):1723-9
http://linkinghub.elsevier.com/retrieve/pii/S0140673603133752
HSL18152
Mayor S.
UK government supports measures to cut drug prices in developing countries.
BMJ 2003 May 17; 326:(7398):1056
http://www.bmj.com/cgi/content/full/326/7398/1056-c?view=long&pmid=12750203
HSL18153
Smith R
Need good results? Fiddle them
BMJ 2003 May 17; 326:(7398):
http://www.bmj.com/cgi/content/full/326/7398/0-e
HSL18155
Is this journalism that makes a difference? The BBC's Panorama programme on Seroxat
BMJ 2003 May 17; 326:(7398):1093
http://www.bmj.com/cgi/content/full/326/7398/1093
HSL20288
Morton V, Torgerson DJ
Effect of regression to the mean on decision making in health care
BMJ 2003 May 17; 326:(7398):1083–1084
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125994/
HSL1124
Grady D.
U.S. Lowers 'Normal' Levels for Blood Pressure Readings
NY Times 2003 May 15
http://www.nytimes.com/2003/05/14/health/14CND-BLOO.html
HSL1125
Zwillich T.
Lawmakers OK Bill to Stop Rx Coercion in Schools
Reuters Health 2003 May 15
HSL1127
Pallarito K.
New Primary Care Journal Refuses Drug Ads
Reuters Health 2003 May 15
HSL9768
Eriksen SA, Nilsen JS, Spigset O, Slordal L.
Selective COX-2 inhibitors--attitudes and prescription habits among general practitioners
Tidsskr Nor Laegeforen. 2003 May 15; 123:(10):1334-7
HSL18154
Moynihan R
Blurring the boundaries: Are sponsored news programmes a new form of paid fronts for the pharmaceutical industry?
BMJ 2003 May 15; 326:(7398):1094
http://www.bmj.com/cgi/content/full/326/7398/1094
HSL1122
Pfizer Launches 'Zoloft For Everything' Ad Campaign
The Onion (Parody) 2003 May 14
http://www.theonion.com/articles/pfizer-launches-zoloft-for-everything-ad-campaign,297/
HSL1123
Ryerson-cruz G.
Cost of testing drugs quadrupled, study says
Bloomberg News 2003 May 14
HSL18156
Relman AS; ACCME.
Defending professional independence: ACCME's proposed new guidelines for commercial support of CME.
JAMA 2003 May 14; 289:(18):2418-20
http://jama.ama-assn.org/cgi/content/full/289/18/2418
HSL18157
Baird P.
Getting it right: industry sponsorship and medical research.
CMAJ 2003 May 13; 168:(10):1267-9
http://www.cmaj.ca/cgi/content/full/168/10/1267
HSL18158
Yeo M.
Marketing Rx&D: one step forward, two steps back.
CMAJ 2003 May 13; 168:(10):1273-4
http://www.cmaj.ca/cgi/content/full/168/10/1273
HSL18159
Hanson D
Marketing Rx&D: the CMA president responds
CMAJ 2003 May 13; 168:(10):1274
http://www.cmaj.ca/cgi/content/full/168/10/1274
HSL1121
Pfizer Narrows Field on Big Assignments
The New York Times 2003 May 12
http://www.nytimes.com/2003/05/12/business/media/12ADDE.html?pagewanted=all&position=
HSL1118
Brook R.
Drug Safety
2003 May 10
HSL1119
Chaddock G.
Profits, politics, and a drug patent: A controversial draft bill offers glimpse of the close dance between a giant drug company and two key senators.
The Christian Science Monitor 2003 May 10
HSL1120
European Union pharmaceutical legislation review
Health Action International 2003 May 10
HSL7641
Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P.
Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis.
BMJ 2003 May 10; 326:(7397):1008
http://www.bmj.com/cgi/content/full/326/7397/1008
HSL18160
Burton B.
Complementary medicines industry in crisis after recall of 1546 products.
BMJ 2003 May 10; 326:(7397):1001
http://www.bmj.com/cgi/content/full/326/7397/1001/a?view=long&pmid=12742903
HSL18161
Dyer O.
Lundbeck broke advertising rules.
BMJ 2003 May 10; 326:(7397):1004
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125924/?tool=pubmed
HSL18162
Dunn N.
10-minute consultation: adverse drug event.
BMJ 2003 May 10; 326:(7397):1018
http://www.bmj.com/cgi/content/full/326/7397/1018?view=long&pmid=12742925
HSL18164
Leucht S, Wahlbeck K, Hamann J, Kissling W.
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.
Lancet 2003 May 10; 361:(9369):1581-9
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)13306-5
HSL1116
Wallace M.
Schizophrenia drug claims questioned
BBC News 2003 May 9
HSL1117
Frisch D.
Media May Mislead on Drug Study Stories
Reuters Health 2003 May 9
HSL1114
Graham M.
Democracy by Disclosure: The Rise of Technopopulism
2003 May 8
HSL1110
Some News Anchors Paid by Drug Companies
New York Times 2003 May 7
HSL1111
Petersen M.
A Respected Face, but Is It News or an Ad?
The New York Times 2003 May 7
http://www.nytimes.com/2003/05/07/business/media/07DRUG.html
HSL1113
Aaron Brown Turning Pr Flack For Phoney 'Newscasts'
New York Times 2003 May 7
HSL1097
Woodman R.
Generics spark cholesterol drug war in UK, Germany
Reuters 2003 May 5
HSL1108
Abelson R.
For Glaxo, the Answers Are in the Pipeline
The New York Times 2003 May 4
HSL1098
Boseley S.
Seroxat maker abandons 'no addiction' claim: Firm agrees to alter leaflet to patients after complaints
The Guardian 2003 May 3
http://www.guardian.co.uk/society/2003/may/03/medicineandhealth.lifeandhealth
HSL1102
Sweet M.
GlaxoSmithKline takes legal action to block new controls on its smoking cessation drug
BMJ 2003 May 3
http://www.bmj.com/cgi/content/extract/326/7396/952/a
HSL1104
Hope J.
Doctors' Children Avoid MMR in UK
Daily Mail 2003 May 3
http://www.dailymail.co.uk/health/article-179088/Doctors-children-avoid-MMR.html
HSL1106
Gilles G.
Study: Prescription Drug Ads Promote Patient-Doctor Communication
Yale New Haven Health System 2003 May 3
HSL16747
Wolfe SM
Democracy by Disclosure: The Rise of Technopopulism (Book Review)
NEJM 2003 May 3; 348:19
HSL18165
Dorozynski A
French government cuts payments for 'moderately useful' drugs
BMJ 2003 May 3; 326:(7396):951
http://www.bmj.com/cgi/content/full/326/7396/951/b
HSL18168
Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, Tran CT.
Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence.
BMJ 2003 May 3; 326:(7396):960-1
http://www.bmj.com/cgi/content/full/326/7396/960?view=long&pmid=12727769
HSL18169
Mayor S
Helpline for patients to report adverse reactions is piloted in England
BMJ 2003 May 3; 326:(7396):951
http://www.bmj.com/cgi/content/full/326/7396/951
HSL18170
Aronson J
TV: Dying for Drugs
BMJ 2003 May 3; 326:(7396):990
http://www.bmj.com/cgi/content/full/326/7396/990
HSL1095
AstraZeneca cancer drug linked to 69 new deaths
Reuters 2003 May 2
HSL1088
A Friend Indeed
Newspapers highlight benefits of new drugs, ignore risks
2003 May 01
HSL1092
Pharmaceutical Sales Force Excellence: Medicaid Market Tactics that Increase Sales
BUSINESS WIRE 2003 May 1
HSL1899
Shani S.
[E-commerce of pharmaceuticals]
Harefuah. 2003 May 01; 142:(5):372-6, 397, 396
HSL1191
Ma J, Stafford R, Cockburn I, Finkelstein S.
A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998
Clin Ther 2003 May; 25:(5):1503-17
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-491PWHT-F&_coverDate=05%2F31%2F2003&_alid=305698650&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=237c0513c114f43d1946b9773feb4e9e
HSL1201
Kocs D, Fendrick AM.
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
Am J Manag Care 2003 May; 9:(5):393-400
http://web.archive.org/web/20070527141019/http://www.cbc.ca/disclosure/archives/040217_adr/resources.html
HSL1229
Cline RJ.
At the intersection of micro and macro: opportunities and challenges for physician-patient communication research.
Patient Educ Couns 2003 May; 50:(1):13-6
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBC-48CG0WX-9&_coverDate=05%2F31%2F2003&_alid=272783093&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5139&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5ebae07eeb92b44d334068747b9d8b54
HSL1236
Burgmer M, Driesch G, Heuft G.
[The "Sisi syndrome": a new form of depression?]
Nervenarzt 2003 May; 74:(5):440-4
HSL1418
Jureidini J, Tonkin A.
Paroxetine in major depression.
J Am Acad Child Adolesc Psychiatry 2003 May; 42:(5):514
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0890-8567&volume=42&issue=5&spage=514
HSL2343
Brody H.
Pens and other pharmaceutical industry gifts.
Am J Bioeth 2003 Summer; 3:(3):58-60
HSL7396
Parry V.
The Art of Branding a Condition
Medical Marketing and Media 2003 May; 42-49
http://www.mmm-online.com/content/fileadmin/files/features/2003/CONDITION.pdf
HSL9747
The truth is out there.
Lancet Neurol. 2003 May; 2:(5):261
http://linkinghub.elsevier.com/retrieve/pii/S1474442203004010
HSL10378
Schiano TD.
Hepatotoxicity and complementary and alternative medicines.
Clin Liver Dis 2003 May; 7:(2):453-73
HSL10464
Williams SA, Ray A.
The impact of clinical technologies on R& D productivity
Current Drug Discovery 2003 May; 17-22
HSL10472
Nathwani D.
Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
J Antimicrob Chemother 2003 May; 51:
http://jac.oxfordjournals.org/cgi/reprint/51/suppl_2/ii37
HSL10488
Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T.
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.
Clin Pharmacol Ther 2003 May; 73:(5):435-55
HSL18171
Sorokin M, Mansfield PR.
Revealing all.
Lancet Infect Dis 2003 May; 3:(5):270-1
http://linkinghub.elsevier.com/retrieve/pii/S1473309903006029
HSL1087
Boseley S.
Drugs firm broke advertising rules
The Guardian 2003 Apr 30
http://www.guardian.co.uk/media/2003/apr/30/advertising.medicineandhealth
HSL1085
Ackerman T.
Doctors aim to end conflicts of interest: Cancer specialists issue new guidelines
Houston Chronicle 2003 Apr 29
Page 125 of 144 pages ‹ First < 123 124 125 126 127 > Last ›
